Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells

International Journal of Cancer

Volumn 92, Issue 6, 2001, Pages 877-882

  Weiss, Helmut ^a   Amberger, Albert ^a   Widschwendter, Martin ^a   Margreiter, Raimund ^a   Öfner, Dietmar ^a   Dietl, Paul ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Anti inflammatory drugs; Apoptosis; Calcium channel; Calcium entry; Cell cycle; Colon cancer; Proliferation

Indexed keywords

ACETYLSALICYLIC ACID; LANTHANUM; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC SULFIDE; THAPSIGARGIN; TRIAZOLE DERIVATIVE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG POTENCY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; CALCIUM; CELL CYCLE; CELL DIVISION; CELL SEPARATION; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; INHIBITORY CONCENTRATION 50; LANTHANUM; LIPID METABOLISM; MEFENAMIC ACID; PYRIDINES; SULINDAC; THAPSIGARGIN; TIME FACTORS; TRIAZOLES; TUMOR CELLS, CULTURED;

EID: 0035877069     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1280     Document Type: Article

References (57)

1. Smalley WE, DuBois RN. Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv Pharmacol 1997;39:1-20.
2. Levy GN, Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J 1997;11:234-7.
3. Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 1997;113:1992-8.
4. Giardiello FM, Offerhaus GJ, DuBois RN. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Eur J Cancer 1995;31A:1071-6.
5. Williams CS, Smalley W, DuBois RN. Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 1997;100: 1325-9.
6. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93:705-16.
7. Elder DJ, Paraskeva C. COX-2 inhibitors for colorectal cancer. Nat Med 1998;4:392-3.
8. Abramson SB, Leszczynska-Piziak J, Haines K, Reibman J. Non-steroidal anti-inflammatory drugs: effects on a GTP binding protein within the neutrophil plasma membrane. Biochem Pharmacol 1991; 41:1567-73.
9. Flescher E, Fossum D, Gray PJ, Fernandes G, Harper MJ, Talal N. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations. J Immunol 1991;146:2553-9.
10. Jung F, Selvaraj S, Gargus JJ. Blockers of platelet-derived growth factor-activated nonselective cation channel inhibit cell proliferation. Am J Physiol 1992;262:C1464-70.
11. Mair N, Frick M, Meraner A, Schramek H, Dietl P. Long-term induction of a unique Cl-current by endothelin-I in an epithelial cell line from rat lung: evidence for regulation of cytoplasmic calcium. J Physiol (Lond) 1998;511:55-65.
12. Cole K, Kohn E. Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev 1994;13:31-44.
13. Hupe DJ, Boltz R, Cohen CJ, et al. The inhibition of receptor-mediated and voltage-dependent calcium entry by the anti-proliferative L-651,582. J Biol Chem 1991;266:10136-42.
14. Kohn EC, Felder CC, Jacobs W, et al. Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. Cancer Res 1994;54:935-42.
15. Kohn EC, Alessandro R, Spoonster J, Wersto RP, Liotta LA. Angiogenesis: role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 1995;92:1307-11.
16. Berlin J, Tutsch KD, Hutson P, et al. Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor. J Clin Oncol 1997;15:781-9.
17. Kohn EC, Figg WD, Sarosy GA, et al. Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations. J Clin Oncol 1997;15:1985-93.
18. Santella L, Kyozuka K, De-Riso L, Carafoli E. Calcium, protease action, and the regulation of the cell cycle. Cell Calcium 1998;23: 123-30.
19. Nicotera P, Orrenius S. The role of calcium in apoptosis. Cell Calcium 1998;23:173-80.
20. Bootman MD, Berridge MJ. The elemental principles of calcium signaling. Cell 1995;83:675-8.
21. Lipp P, Thomas D, Berridge MJ, Bootman MD. Nuclear calcium signalling by individual cytoplasmic calcium puffs. EMBO J 1997; 16:7166-73.
22. Putney-JW J, Bird GS. The signal for capacitative calcium entry. Cell 1993;75:199-201.
23. Zinkand W, Wawara EJ, Falcone RC, Patel J, Christian EP. Dipyridyltriazoles: a novel series of store-operated calcium channel blockers. Biophys J 1998;74:A376.
24. Elder DJ, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 1997; 3:1679-83.
25. Elstein KH, Zucker RM. Comparison of cellular and nuclear flow cytometric techniques for discriminating apoptotic subpopulations. Exp Cell Res 1994;211:322-31.
26. Darzynkiewicz Z, Bruno S, Del-Bino G, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
27. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
28. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 1998;31:1-9.
29. Hixson LJ, Alberts DS, Krutzsch M, et al. Anti-proliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev 1994;3:433-8.
30. Berridge MJ, Capacitative calcium entry. Biochem J 1995;312:1-11.
31. 2+ current in Xenopus oocytes requires SNAP-25 but not a diffusible messenger. Cell 1999;98:475-85.
32. 2+ entry: evidence for a secretion-like coupling model. Cell 1999;98:487-99.
33. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
34. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80:1618-9.
35. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 1998;95:681-6.
36. Shiff SJ, Rigas B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med 1999;190:445-50.
37. Kubba AK. Non steroidal anti-inflammatory drugs and colorectal cancer: is there a way forward? Eur J Cancer 1999;35:892-901.
38. Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995;96:491-503.
39. Piazza GA, Alberts DS, Hixson LJ, et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997;57:2909-15.
40. Zhang X, Morham SG, Langenbach R, Young DA. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 1999;190:451-9.
41. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 1998;48:1936-42.
42. Shiff SJ, Koutsos MI, Qiao L, Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 1996;222:179-88.
43. Ricchi P, Pignata S, Di Popolo A, et al. Effect of aspirin on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells. Int J Cancer 1997;73:880-4.
44. Hong SH, Avis I, Vos MD, Martinez A, Treston AM, Mulshine JL. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res 1999;59:2223-8.
45. McConkey DJ, Orrenius S. The role of calcium in the regulation of apoptosis. Biochem Biophys Res Commun 1997;239:357-66.
46. Putney-JW J, McKay RR. Capacitative calcium entry channels. Bioessays 1999;21:38-46.
47. 2+ entry. Naunyn Schmiedebergs Arch Pharmacol 1999;359:92-101.
48. Schwarz G, Droogmans G, Nilius B. Multiple effects of SK&F 96365 on ionic currents and intracellular calcium in human endothelial cells. Cell Calcium 1994;15:45-54.
49. Golovina VA. Cell proliferation is associated with enhanced capacitative Ca(2+) entry in human arterial myocytes. Am J Physiol 1999; 277:C343-9.
50. Felder CC, Ma AL, Liotta LA, Kohn EC. The anti-proliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. J Pharmacol Exp Ther 1991;257:967-71.
51. Kohn EC, Reed E, Sarosy G, et al. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers. Cancer Res 1996;56:569-73.
52. Wu Y, Palad AJ, Wasilenko WJ, et al. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole. Clin Cancer Res 1997;3:1915-21.
53. Lepple-Wienhues A, Belka C, Laun T, et al. Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids. Proc Natl Acad Sci USA 1999;96:13795-800.
54. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 1994;15:77-83.
55. 2+]. J Cell Biol 1998;140:325-34.
56. 2+]i oscillations. J Biol Chem 1996;271:21720-5.
57. Berridge MJ, Bootman MD, Lipp P. Calcium - a life and death signal. Nature 1998;395:645-8.